| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
11,874 |
10,592 |
$4.32M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
7,970 |
6,942 |
$3.89M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
10,434 |
9,549 |
$3.50M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
2,115 |
1,983 |
$1.85M |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
1,960 |
1,823 |
$1.34M |
| 70450 |
Computed tomography, head or brain; without contrast material |
3,049 |
2,798 |
$718K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
3,185 |
2,919 |
$653K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
961 |
905 |
$421K |
| G0378 |
Hospital observation service, per hour |
1,417 |
712 |
$271K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
312 |
300 |
$195K |
| 71046 |
Radiologic examination, chest; 2 views |
2,738 |
2,554 |
$113K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
565 |
554 |
$96K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
449 |
434 |
$69K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
1,415 |
1,186 |
$64K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
3,945 |
3,657 |
$58K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
1,179 |
1,132 |
$51K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
3,966 |
3,150 |
$44K |
| 73562 |
|
900 |
777 |
$39K |
| J2704 |
Injection, propofol, 10 mg |
2,868 |
2,445 |
$33K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
8,668 |
7,128 |
$31K |
| 73030 |
|
904 |
806 |
$31K |
| M0247 |
Intravenous infusion, sotrovimab, includes infusion and post administration monitoring |
14 |
14 |
$30K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
4,015 |
3,284 |
$29K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
487 |
442 |
$29K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
78 |
52 |
$24K |
| 71250 |
|
101 |
99 |
$20K |
| 74018 |
|
458 |
400 |
$17K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,663 |
1,425 |
$16K |
| 93971 |
|
165 |
157 |
$16K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
24 |
24 |
$16K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
331 |
235 |
$14K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
51 |
49 |
$13K |
| 72131 |
|
41 |
41 |
$13K |
| 72100 |
|
67 |
65 |
$13K |
| 59025 |
Fetal non-stress test |
338 |
173 |
$12K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
68 |
67 |
$11K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
43 |
39 |
$10K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
45 |
45 |
$9K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
2,755 |
2,463 |
$9K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
7,041 |
5,638 |
$9K |
| 80320 |
|
2,526 |
2,263 |
$8K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
56 |
49 |
$8K |
| 71045 |
Radiologic examination, chest; single view |
6,366 |
5,649 |
$8K |
| 80053 |
Comprehensive metabolic panel |
16,555 |
13,645 |
$7K |
| 73630 |
|
284 |
261 |
$7K |
| 73502 |
|
189 |
160 |
$7K |
| C8929 |
Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography |
12 |
12 |
$7K |
| 77080 |
|
66 |
61 |
$6K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
8,086 |
6,958 |
$6K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
12 |
12 |
$5K |
| 73610 |
|
359 |
331 |
$5K |
| 73130 |
|
282 |
251 |
$5K |
| J3490 |
Unclassified drugs |
10,839 |
5,198 |
$4K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
29 |
14 |
$4K |
| 87631 |
|
804 |
780 |
$4K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
257 |
163 |
$3K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
2,768 |
2,278 |
$3K |
| 72110 |
|
12 |
12 |
$3K |
| 76830 |
Ultrasound, transvaginal |
256 |
248 |
$3K |
| 76801 |
|
27 |
26 |
$3K |
| 73110 |
|
78 |
70 |
$2K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
3,362 |
3,149 |
$2K |
| 84702 |
|
1,015 |
880 |
$1K |
| 84443 |
Thyroid stimulating hormone (TSH) |
841 |
757 |
$751.72 |
| A9270 |
Non-covered item or service |
10,429 |
2,531 |
$689.63 |
| 86850 |
|
170 |
155 |
$591.35 |
| 83880 |
|
1,782 |
1,566 |
$514.13 |
| 94760 |
|
563 |
334 |
$363.42 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
1,422 |
1,023 |
$338.67 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
17,013 |
14,167 |
$330.88 |
| 87186 |
|
747 |
638 |
$233.27 |
| 86769 |
|
196 |
194 |
$199.90 |
| 87077 |
|
1,073 |
884 |
$197.34 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
2,604 |
2,285 |
$173.27 |
| 87040 |
|
1,950 |
947 |
$142.42 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
2,241 |
1,837 |
$126.06 |
| 85027 |
|
2,037 |
1,644 |
$118.20 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
6,854 |
5,693 |
$113.10 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
4,113 |
3,505 |
$108.63 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
675 |
648 |
$102.62 |
| 81001 |
|
6,110 |
5,239 |
$99.92 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
1,471 |
1,092 |
$94.53 |
| 83690 |
|
4,941 |
4,302 |
$93.14 |
| 82947 |
|
3,840 |
2,605 |
$67.47 |
| 81025 |
|
1,771 |
1,644 |
$54.06 |
| 83735 |
|
2,160 |
1,750 |
$47.42 |
| 84484 |
|
7,513 |
4,715 |
$47.13 |
| 83605 |
|
3,581 |
2,782 |
$39.64 |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
1,132 |
726 |
$35.71 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
698 |
329 |
$34.21 |
| 36415 |
Collection of venous blood by venipuncture |
100 |
72 |
$23.78 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
2,448 |
2,120 |
$19.10 |
| 81003 |
|
3,144 |
2,842 |
$16.07 |
| J8499 |
Prescription drug, oral, non chemotherapeutic, nos |
7,949 |
4,498 |
$15.87 |
| 85014 |
|
31 |
27 |
$15.68 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
466 |
369 |
$15.48 |
| 85379 |
|
393 |
362 |
$12.32 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
2,099 |
1,800 |
$10.71 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
5,005 |
4,367 |
$10.68 |
| 85610 |
|
2,572 |
2,267 |
$7.43 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
2,037 |
1,816 |
$7.32 |
| 84703 |
|
1,029 |
988 |
$4.81 |
| 85007 |
|
100 |
89 |
$2.71 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
105 |
71 |
$0.00 |
| 86900 |
|
214 |
198 |
$0.00 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
493 |
472 |
$0.00 |
| 96367 |
|
217 |
159 |
$0.00 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
769 |
631 |
$0.00 |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
40 |
38 |
$0.00 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
985 |
834 |
$0.00 |
| J1596 |
Injection, glycopyrrolate, 0.1 mg |
13 |
13 |
$0.00 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
55 |
38 |
$0.00 |
| 90715 |
|
182 |
179 |
$0.00 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
54 |
50 |
$0.00 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
130 |
120 |
$0.00 |
| 80076 |
|
14 |
13 |
$0.00 |
| 82565 |
|
26 |
26 |
$0.00 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
52 |
51 |
$0.00 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
25 |
12 |
$0.00 |
| 84520 |
|
27 |
27 |
$0.00 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
23 |
14 |
$0.00 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
33 |
27 |
$0.00 |
| 85055 |
|
14 |
12 |
$0.00 |
| 87088 |
|
2,029 |
1,740 |
$0.00 |
| 96376 |
|
2,091 |
1,425 |
$0.00 |
| J1630 |
Injection, haloperidol, up to 5 mg |
179 |
162 |
$0.00 |
| 85730 |
|
553 |
484 |
$0.00 |
| J7999 |
Compounded drug, not otherwise classified |
208 |
200 |
$0.00 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
998 |
725 |
$0.00 |
| 86901 |
|
246 |
225 |
$0.00 |
| J8597 |
Antiemetic drug, oral, not otherwise specified |
584 |
489 |
$0.00 |
| 73090 |
|
14 |
12 |
$0.00 |
| Q0247 |
Injection, sotrovimab, 500 mg |
16 |
14 |
$0.00 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
201 |
197 |
$0.00 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
614 |
537 |
$0.00 |
| J2060 |
Injection, lorazepam, 2 mg |
709 |
568 |
$0.00 |
| 80329 |
|
114 |
97 |
$0.00 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
71 |
67 |
$0.00 |
| J1815 |
Injection, insulin, per 5 units |
74 |
39 |
$0.00 |
| 86140 |
|
608 |
556 |
$0.00 |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
52 |
50 |
$0.00 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
99 |
68 |
$0.00 |
| 87807 |
|
133 |
127 |
$0.00 |
| 87081 |
|
151 |
147 |
$0.00 |
| J3480 |
Injection, potassium chloride, per 2 meq |
20 |
12 |
$0.00 |
| J0456 |
Injection, azithromycin, 500 mg |
14 |
12 |
$0.00 |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
105 |
100 |
$0.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
224 |
214 |
$0.00 |
| 82550 |
|
45 |
42 |
$0.00 |
| 85018 |
|
31 |
27 |
$0.00 |
| 82270 |
|
12 |
12 |
$0.00 |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
18 |
12 |
$0.00 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
16 |
16 |
$0.00 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
31 |
30 |
$0.00 |
| 96368 |
|
16 |
12 |
$0.00 |
| A9579 |
Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml |
12 |
12 |
$0.00 |